BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8402661)

  • 1. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
    Davies SM
    Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease.
    Takeda S; Kondo M; Kumada T; Koshikawa T; Ueda R; Nishio M; Osada H; Suzuki H; Nagatake M; Washimi O; Takagi K; Takahashi T; Nakao A; Takahashi T
    Oncogene; 1996 Apr; 12(7):1589-92. PubMed ID: 8622877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
    Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
    Wu HK; Squire JA; Catzavelos CG; Weksberg R
    Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of imprinting in hepatoblastoma.
    Rainier S; Dobry CJ; Feinberg AP
    Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
    Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
    Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
    Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
    J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia.
    Wu HK; Weksberg R; Minden MD; Squire JA
    Biochem Biophys Res Commun; 1997 Feb; 231(2):466-72. PubMed ID: 9070302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer.
    Yun K; Fukumoto M; Jinno Y
    Am J Pathol; 1996 Apr; 148(4):1081-7. PubMed ID: 8644850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice.
    Haddad R; Held WA
    Cancer Res; 1997 Oct; 57(20):4615-23. PubMed ID: 9377577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative reverse transcription-polymerase chain reaction and in situ hybridization analyses of human imprinted p57KIP2 and insulin-like growth factor 2 gene transcripts in fetal kidney and Wilms' tumors using archival tissue.
    Soejima H; McLay J; Hatada I; Mukai T; Jinno Y; Niikawa N; Yun K
    Lab Invest; 1998 Jan; 78(1):19-28. PubMed ID: 9461119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
    Vu TH; Chuyen NV; Li T; Hoffman AR
    Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter-specific imprinting of the human insulin-like growth factor-II gene.
    Vu TH; Hoffman AR
    Nature; 1994 Oct; 371(6499):714-7. PubMed ID: 7935819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma.
    Albrecht S; von Schweinitz D; Waha A; Kraus JA; von Deimling A; Pietsch T
    Cancer Res; 1994 Oct; 54(19):5041-4. PubMed ID: 7923113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas.
    Casola S; Ungaro P; Pedone PV; Lazzaro D; Fattori E; Ciliberto G; Zarrilli R; Bruni CB; Riccio A
    Oncogene; 1995 Aug; 11(4):711-21. PubMed ID: 7651735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma.
    Montagna M; Menin C; Chieco-Bianchi L; D'Andrea E
    J Cancer Res Clin Oncol; 1994; 120(12):732-6. PubMed ID: 7798299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues.
    Jarrard DF; Bussemakers MJ; Bova GS; Isaacs WB
    Clin Cancer Res; 1995 Dec; 1(12):1471-8. PubMed ID: 9815946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental origin of 11p15 deletions in human lung cancer.
    Kondo M; Suzuki H; Ueda R; Takagi K; Takahashi T; Takahashi T
    Oncogene; 1994 Oct; 9(10):3063-5. PubMed ID: 7916149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma.
    Wada M; Seeger RC; Mizoguchi H; Koeffler HP
    Cancer Res; 1995 Aug; 55(15):3386-8. PubMed ID: 7614476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
    Wang WH; Duan JX; Vu TH; Hoffman AR
    J Biol Chem; 1996 Nov; 271(44):27863-70. PubMed ID: 8910385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.